C-Reactive Protein Levels: What Your hs-CRP Means

By Dr. Matt Gianforte, D.C. | Functional Medicine Clinician

C-reactive protein (CRP) is a liver protein that rises with inflammation. On a standard CRP test, most healthy adults are below 0.3 mg/dL; on a high-sensitivity (hs-CRP) test used for heart risk, below 1.0 mg/L is lower risk, 1.0 to 3.0 mg/L average, and above 3.0 mg/L higher risk. A high result is a signal to find the cause, not a diagnosis.

A lab report can make C-reactive protein levels feel confusing. One result may be flagged high because the body is responding to an infection, while another uses a more sensitive test to estimate cardiovascular risk. The number matters, but its meaning depends on which assay was used, the units reported, your symptoms, and whether inflammation is temporary or persistent.

• CRP is made by the liver after inflammatory signals tell the body to respond.
• Standard CRP is mainly useful for evaluating substantial inflammation linked to infection, injury, or inflammatory disease.
• High-sensitivity CRP, or hsCRP, measures lower concentrations used in cardiovascular risk stratification.
• A high result doesn't diagnose a disease by itself. It points toward the need for context and follow-up.
• Persistently increased results can prompt evaluation of metabolic, immune, infectious, periodontal, gut, sleep, and environmental contributors.
• The safest approach combines repeat testing, symptom review, cardiovascular assessment, and individualized lifestyle or medical care.

Why Your C Reactive Protein Levels Matter More Than You Think

A patient may stare at a lab printout and see “CRP high” highlighted in red. The immediate question is usually, “What disease do I have?” The more accurate question is, “What is signaling inflammation, and which CRP test was ordered?”

C-reactive protein is produced by the liver when inflammatory signals, particularly interleukin-6, activate an acute-phase response. In practical terms, CRP acts as a responsive barometer of inflammation somewhere in the body. It doesn't identify the exact location or cause, and it can't distinguish every infection, injury, autoimmune process, or metabolic trigger on its own. MedlinePlus explains that healthy people generally have very low CRP and that an increase can indicate inflammation in the body through its overview of the C-reactive protein CRP test.

The test's purpose changes the interpretation. A conventional CRP test is generally used when a clinician is evaluating more substantial inflammation, such as infection, tissue injury, or inflammatory disease. hsCRP uses a more sensitive assay to detect lower concentrations, which can help estimate cardiovascular risk when a person isn't experiencing an acute illness. The chronic inflammation guide explains how this marker fits into a wider inflammation workup.

Why a normal cholesterol result doesn't settle the question

Inflammation can contribute to atherosclerotic risk even when a standard lipid panel appears reassuring. In a large prospective study of U.S. health professionals, participants with CRP values of at least 3.0 mg/L had a relative risk of 1.79 for coronary heart disease compared with participants below 1.0 mg/L (Pai et al., New England Journal of Medicine, 2004). That finding doesn't mean a high result guarantees a heart attack. It means inflammation adds information that cholesterol alone may not capture.

In the Reykjavik Study, people in the top third of CRP values had about 1.45 times the odds of coronary heart disease compared with the bottom third after adjustment for established risk factors, and an updated meta-analysis of 22 prospective studies (7,068 patients with coronary heart disease) found similar results. The authors called CRP a relatively moderate predictor (Danesh et al., New England Journal of Medicine, 2004). The key clinical distinction is simple: standard CRP helps investigate what may be inflaming the body now, while hsCRP can help refine longer-term cardiovascular risk.

That distinction supports a root-cause approach. Instead of treating the marker as the disease, clinicians can examine the metabolic, immune, infectious, periodontal, gut, sleep, and lifestyle conditions that may be keeping inflammatory signaling active. Background on those contributors appears in this guide to what causes chronic inflammation in the body.

CRP Versus hsCRP and What the Numbers Measure

Standard CRP and hsCRP measure the same protein, which the liver produces during inflammatory signaling. Their difference lies in how precisely the laboratory assay detects low concentrations and which clinical question the test is intended to address.

The two tests work like rulers with different levels of detail. Standard CRP is suited to larger changes that may accompany infection, injury, or inflammatory disease. hsCRP measures smaller changes that can add information about low-grade inflammation and cardiovascular risk.

Feature	Standard CRP	High-Sensitivity CRP, hsCRP
Main purpose	Evaluate substantial inflammation	Refine cardiovascular risk
Typical clinical question	Could infection, injury, or inflammatory disease be active?	Is low-grade inflammation adding cardiovascular risk information?
Reporting context	Often interpreted with symptoms, examination, and other inflammatory tests	Interpreted with lipids, blood pressure, glucose status, smoking history, and family history
Meaning of elevation	Suggests an inflammatory process, but not its exact cause	Suggests higher or lower risk within an appropriate prevention assessment
Key limitation	May not provide useful detail at very low concentrations	Can be distorted by acute illness, injury, or chronic inflammatory disease

Why the test name matters

A standard CRP result and an hsCRP result use different interpretive frameworks. For cardiovascular assessment, the American Heart Association and CDC commonly use less than 1.0 mg/L for low risk, 1.0 to 3.0 mg/L for average risk, and above 3.0 mg/L for high risk (Pearson et al., CDC/AHA scientific statement, Circulation, 2003).

Conventional CRP is usually read in the context of acute inflammation. MedlinePlus states that most healthy adults have CRP below 0.3 mg/dL, while 0.3 to 1.0 mg/dL is a minor rise of unclear significance, 1.0 to 10.0 mg/dL a moderate increase and above 10 mg/dL a marked increase (MedlinePlus, C-reactive protein).

The unit on the report also matters. Results may appear in mg/L or mg/dL, and one mg/dL equals ten mg/L. Comparing a result with a reference range requires matching the units first.

A low hsCRP value does not rule out every inflammatory condition, just as a high standard CRP does not identify the cause by itself. Symptoms, timing, medical history, and related testing provide the context. For more background, review this guide to inflammatory markers in laboratory testing.

Reading Your Results From Low Risk to Severe Elevation

The first step is identifying whether the report lists CRP or hsCRP. The same molecule can support different clinical decisions, and a value that matters for cardiovascular risk may be far below the range associated with a serious acute infection.

hsCRP cardiovascular categories

The widely used hsCRP categories are:

• Below 1.0 mg/L: lower cardiovascular risk category.
• 1.0 to 3.0 mg/L: average or intermediate cardiovascular risk category.
• Above 3.0 mg/L: higher cardiovascular risk category.

In a prevention setting, the higher category doesn't prove that arterial disease exists. It indicates that the result may add risk information when considered alongside cholesterol, blood pressure, glucose regulation, smoking history, family history, and other clinical factors. An hs-CRP of 2.0 mg/L or higher is listed as a risk-enhancing factor in the 2019 ACC/AHA primary prevention guideline (Arnett et al., Circulation, 2019).

A value above 10 mg/L requires caution. Acute illness, injury, or another inflammatory event may be responsible, so a clinician typically considers repeating the test after the temporary trigger has resolved rather than using it immediately for cardiovascular stratification.

Standard CRP elevation

Standard CRP interpretation often uses these broad categories:

• Below 0.3 mg/dL: generally normal.
• 0.3 to 1.0 mg/dL: minor elevation.
• 1.0 to 10.0 mg/dL: moderate elevation.
• Above 10.0 mg/dL: marked elevation.
• Above 50.0 mg/dL: severe elevation, as described in the StatPearls CRP reference.

The highest results can occur with bacterial infection, major trauma, or substantial tissue injury. The result still needs clinical interpretation because CRP alone doesn't identify the source. Recent illness, strenuous exercise, hormonal changes, diabetes, obesity, smoking, autoimmune activity, and unresolved injury can all influence the baseline or create temporary changes. The patient's symptoms and examination remain central.

Practical rule: A number becomes clinically useful only when the assay, units, timing, symptoms, and surrounding laboratory findings are considered together.

Root Cause Drivers Behind Persistently Elevated CRP

A persistently high CRP signals ongoing inflammation that requires investigation beyond the number itself. CRP is produced by the liver after inflammatory signals, including cytokines, reach it. The result therefore points toward an active process, while symptoms, history, and additional testing help identify the source.

Six common investigative pathways

1. Chronic low-grade infections may keep immune signaling active. Periodontal disease, recurrent urinary problems, and selected viral concerns merit evaluation when symptoms or medical history support them. Testing should target a reasonable clinical question rather than serve as a broad search.
2. Metabolic dysfunction often includes insulin resistance and visceral adiposity, the metabolically active fat surrounding internal organs. Adipose tissue can release inflammatory signals, and impaired glucose regulation may maintain low-level immune activation.
3. Gut barrier disruption refers to increased intestinal permeability, sometimes called “leaky gut.” Dysbiosis and impaired barrier function may expose immune cells to gut-derived molecules, sustaining inflammation in susceptible people. For a practical explanation of this pathway, see how to heal gut inflammation.
4. Autoimmune activity can keep inflammatory pathways active even when symptoms come and go. Immune cells release cytokines such as interleukin-6, which signals the liver to produce more CRP.
5. Smoking and air pollution can increase oxidative stress and irritate respiratory and vascular tissues. Their relevance depends on exposure, symptoms, and the broader health context.
6. Unresolved tissue stress includes musculoskeletal injury and sleep-disordered breathing. Repeated strain or intermittent oxygen disruption during sleep may prolong inflammatory signaling.

Functional medicine practitioners usually start by asking whether the result was a standard CRP or an hs-CRP, whether the person was sick, injured or training hard that week, and what else is on the panel, before deciding what to look at next.

CRP becomes more useful through diagnostic pairing. A clinician may compare it with metabolic markers, blood counts, symptom-directed infection testing, periodontal assessment, autoimmune testing, or gut evaluation. This approach connects the biomarker with physiology and helps distinguish a temporary response from an ongoing driver, rather than treating the laboratory result alone.

What to Test Next When CRP Comes Back High

A high CRP result deserves context before it leads to a supplement plan or cardiovascular decision. The follow-up pathway depends on the value, whether the test was standard CRP or hsCRP, current symptoms, and recent illness or injury.

For standard CRP, a clinician may repeat the test in two to four weeks when a temporary viral illness or other short-lived trigger could explain the result. For hsCRP, the goal is often to confirm a pattern after the person is well and to compare the result with the broader cardiovascular profile. Any clinician-directed retest should follow the timing appropriate to the patient's presentation.

Follow-up testing pathway

Scenario	Recommended next tests	Specialist referral
Mild or unexplained elevation	Repeat CRP, complete blood count, ferritin, symptom review	Primary care clinician if persistent
Cardiovascular risk question	hsCRP, fasting lipids, ApoB, glucose assessment, blood pressure review	Cardiovascular evaluation when overall risk warrants it
Metabolic concern	Fasting insulin with HOMA-IR, hemoglobin A1c, fasting lipids	Metabolic or primary care support
Gut symptoms	Symptom-directed gastrointestinal evaluation, with stool testing when clinically appropriate	Gastroenterology or qualified functional medicine assessment
Dental symptoms or periodontal concerns	Periodontal examination	Dental professional
Autoimmune symptoms	Condition-directed immune testing and physical examination	Rheumatology or another relevant specialist

Ferritin and homocysteine can add context, but neither identifies the cause of CRP elevation alone. A clinician may also consider the intestinal permeability testing pathway when gastrointestinal symptoms, dietary reactions, or bowel changes make gut evaluation relevant.

Chest pain, unexplained weight loss, persistent fever, or a rapid CRP rise warrant prompt medical assessment. Those findings shouldn't be managed through repeated self-testing.

A Functional Medicine Protocol to Lower Inflammation

A functional medicine protocol treats CRP as a signal, not a diagnosis. Like a dashboard warning light, it can point toward modifiable influences such as diet, sleep, stress, activity, or gut symptoms, while infection, autoimmune disease, and cardiovascular risk still require appropriate medical evaluation.

1. Build meals around anti-inflammatory foods

A Mediterranean-style pattern centers on vegetables, legumes, whole-food fiber, berries, herbs, nuts, seeds, and olive oil. Fiber supports bowel regularity and microbial fermentation. Polyphenols in berries and olive oil provide plant compounds that interact with inflammatory pathways. Choosing a fresh, good-quality extra-virgin olive oil and using it daily matters more than any single “superfood.”

Some protocols discuss more than 30 grams of fiber daily, and a review of omega-3 research concluded that an EPA plus DHA intake greater than 2 grams daily seems to be needed for anti-inflammatory effects in adults (Calder, British Journal of Clinical Pharmacology, 2013). Individual needs vary with tolerance, diet, medications, kidney function, and clinician guidance. Ultra-processed foods, frequent refined starches, and excess alcohol can make metabolic and digestive goals harder to maintain.

2. Treat sleep as an inflammatory intervention

Regular sleep and wake times support nervous-system regulation. Persistent snoring, morning headaches, witnessed breathing pauses, or unrefreshing sleep deserve clinical discussion because obstructive sleep apnea can maintain physiological stress. A plan might include sleep evaluation, morning light, a consistent wind-down routine, and less late-evening stimulation.

3. Regulate stress physiology

Paced breathing, meditation, gentle mobility, and heart-rate-variability biofeedback may reduce repeated sympathetic activation. Consistency matters more than intensity. A brief daily practice is often easier to sustain than occasional effort that creates more pressure.

4. Use movement without overtraining

Moderate aerobic activity and resistance training support glucose handling, circulation, muscle function, and body composition. A sudden rise in high-intensity exercise can temporarily raise inflammatory markers, particularly when recovery, sleep, or nutrition is inadequate. Progress should reflect fitness, age, injury history, and medical status.

5. Support the gut barrier with food first

Whole-food prebiotic fibers, varied plant foods, tolerated fermented foods, and polyphenol diversity can support a more resilient eating pattern. Some people may need to reduce foods or additives that clearly worsen symptoms, including certain emulsifier-containing products. Elimination diets need a defined purpose and careful reintroduction plan so they do not create unnecessary restriction.

Each intervention should have a clear reason. Nutrition may address metabolic signaling, sleep may target stress physiology, and gut-focused changes may respond to digestive symptoms or barrier support. These steps complement, rather than replace, evaluation for infection, autoimmune disease, or cardiovascular risk.

Targeted Supplements and When to See a Clinician

Supplements can complement a food, sleep, movement, and medical-evaluation plan. They shouldn't be used to explain away a high CRP result or delay care, especially when symptoms suggest infection, autoimmune activity, or cardiovascular disease.

Intervention	Mechanism and educational dose context	When to escalate
Omega-3 EPA and DHA	Supports a healthier balance of lipid-derived inflammatory mediators. Some protocols use 2 to 3 grams daily, individualized to diet and medication use.	Review with a clinician when taking anticoagulants or before surgery.
Curcumin	May influence NF-kB-related inflammatory signaling. Educational protocols often discuss 500 to 1,000 mg with piperine, but formulations and absorption differ.	Obtain medication review, particularly with anticoagulants or immunosuppressants.
Magnesium glycinate	Supports neuromuscular function and may help address stress and sleep factors that interact with inflammation. Common educational contexts discuss 300 to 400 mg, adjusted for kidney function and tolerance.	Seek guidance with kidney disease, significant diarrhea, or interacting medicines.
Vitamin D	Supports immune regulation when deficiency exists. Dosing should follow measured status, with some clinical contexts using 2,000 to 5,000 IU only when appropriate.	Use clinician-guided testing and dosing to avoid excessive intake.
N-acetyl cysteine	Provides cysteine for glutathione synthesis and antioxidant support. Educational protocols may discuss 600 to 1,200 mg.	Review asthma, medication use, and tolerability with a clinician.

Product selection should follow the mechanism, formulation, dose, and safety profile rather than the label alone. Readers comparing options can review the article on natural remedies for inflammation and pain, then discuss suitability with a qualified healthcare professional. Examples in the store include Omega MonoPure 1300 EC fish oil, Curcuma Supreme NF-kB Formula and Magnesium Glycinate Powder, and the full range is in the inflammation collection. For a food-based option, see anti-inflammatory protein powder.

A CRP above 10 mg/L without an obvious cause, persistent elevation beyond 8 to 12 weeks, new chest pain, unexplained weight loss, persistent fever, or autoimmune symptoms warrants clinical evaluation. Supplement use also requires caution with anticoagulants and immunosuppressants because several compounds can affect clotting, immune signaling, or medication response. Don't stop or change a prescribed statin, blood thinner, blood pressure or diabetes medication without talking to your clinician.

Bringing It All Together for Long-Term Inflammation Control

CRP is best understood as a message from the body, not the disease itself. A temporary rise may reflect infection or injury. A persistent elevation may point toward metabolic dysfunction, immune activity, periodontal disease, gut-related concerns, sleep disruption, environmental exposure, or another source that requires a targeted assessment.

A trend is more useful than a single result

hsCRP can change over 6 to 12 weeks when meaningful lifestyle changes alter the factors driving low-grade inflammation. More entrenched metabolic or autoimmune contributors may require 3 to 6 months of consistent work and medical supervision. Those time frames describe monitoring expectations, not guaranteed outcomes, and an individual result can vary with illness, medications, exercise, and other conditions.

A practical monitoring plan may repeat hsCRP at 8 to 12 weeks alongside fasting insulin and lipid markers when cardiovascular or metabolic risk is the concern. The clinician can then compare the direction of change with symptoms, blood pressure, glucose regulation, body composition, medication use, and any condition-specific findings.

The four-part model is straightforward:

1. Assess the signal, including the assay, units, symptoms, and timing.
2. Investigate upstream drivers, rather than treating CRP as the endpoint.
3. Apply targeted changes, then monitor both laboratory trends and clinical response.
4. Adapt the plan, escalating to medical or specialist care when warning signs appear.

A functional medicine approach to a high CRP looks at inflammation, metabolism, gut function, stress response, and nutrient status together. Bring your full lab report, including the test name and units, to your healthcare provider so the next step fits the actual result.

Frequently Asked Questions

What do high C reactive protein levels mean?

High C-reactive protein levels mean that the body is responding to inflammation, but the result doesn't identify the cause by itself. Infection, injury, autoimmune activity, metabolic dysfunction, and other conditions can contribute, so interpretation requires the assay type, units, symptoms, and follow-up evaluation.

What is the difference between CRP and hsCRP?

Standard CRP is generally used to evaluate more substantial inflammation, such as infection or tissue injury. hsCRP measures lower concentrations and is used mainly to refine cardiovascular risk when acute illness and chronic inflammatory disease aren't distorting the result.

Is an hsCRP above 3.0 mg/L dangerous?

An hsCRP above 3.0 mg/L falls into the commonly used higher cardiovascular risk category (Pearson et al., 2003). It doesn't diagnose heart disease, and a clinician should interpret it with the complete cardiovascular profile and consider repeat testing when temporary inflammation may be present.

Can a cold raise CRP?

Yes. An acute infection can raise CRP, which is why a result obtained during illness may not represent a person's usual baseline. Patients should tell the ordering clinician about recent infection, injury, intense exercise, or other short-term stressors.

How can C reactive protein levels be lowered naturally?

The most useful foundation includes a nutrient-dense eating pattern, adequate sleep, appropriately dosed movement, stress regulation, smoking avoidance, and evaluation of conditions that sustain inflammation. Supplements may be considered after medication review and should complement, not replace, diagnosis or treatment.

When should a high CRP result receive urgent attention?

Chest pain, persistent fever, unexplained weight loss, rapid worsening, or a rapid CRP rise deserves prompt medical assessment. A high result without symptoms still warrants appropriate follow-up, particularly when it remains high or exceeds the range expected for routine cardiovascular risk assessment.

Should a high CRP result be treated with supplements?

Not automatically. CRP is a signal, and the correct response depends on whether the source is acute infection, injury, autoimmune activity, metabolic dysfunction, or another condition. A clinician should review medications and medical history before omega-3 products, curcumin, magnesium, vitamin D, or N-acetyl cysteine are added.

References

• Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599-2610. PMID 15602020.
• Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14):1387-1397. PMID 15070788.
• Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the CDC and the AHA. Circulation. 2003;107(3):499-511. PMID 12551878.
• Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):e596-e646. PMID 30879355.
• Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645-662. PMC3575932.
• MedlinePlus. “C-Reactive Protein CRP Test.” Available at MedlinePlus laboratory information.
• MedlinePlus. “C-Reactive Protein.” Available at MedlinePlus medical encyclopedia.
• Nehring SM, Goyal A, Patel BC. C Reactive Protein. In: StatPearls. StatPearls Publishing. NBK441843.
• Lamabadusuriya D, Jayawardene P, Cader FA, et al. High-sensitivity C-reactive protein and its role in coronary atherosclerotic disease: a review of current literature. Postgrad Med J. 102(1203):17-24. PMID 40587771.

These statements have not been evaluated by the Food and Drug Administration. Products and information on this site are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement.